Navigating an executive leadership change? Use our eBook to facilitate a smooth transition. Download Now

Westicke Partners

Close

International Biotech: Accessing the U.S. Capital Markets in a Post-COVID-19 World

Through the coronavirus pandemic, biotech companies have continued to innovate and are turning U.S. capital markets to finance their vision and innovation.

International BiotechnologyInternational Biotech: Accessing the U.S. Capital Markets in a Post-COVID-19 World

July 2020 – Biotech innovations are continuing to advance during the coronavirus pandemic — and many companies are now turning to U.S. capital markets for financing. During this call, a panel of capital markets and biotech experts discussed developments in today’s rapidly changing environment.

Topics covered include:

  • The latest capital markets updates
  • Strategies for outreach to the world’s most sophisticated investors
  • Other issues impacting biotech IPOs, including the upcoming election and an increase in SPAC transactions

Click to view the webinar

Preparing for an investor meeting?

Download our checklist of 6 questions investors will ask to make a decision about your company.

Our Locations